Showing results (511-520 of 668) with videos related to
Sort By:
Pageof 67
European Journal of Clinical Pharmacology|June 24, 1999
Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchangedD Fliser, I Bischoff, A Hanses, et al.Glycoconjugate Journal|October 1, 1995
L-fucose residues on cellulose-based dialysis membranes: quantification of membrane-associated L-fucose and analysis of specific lectin bindingC Meissner, R Deppisch, F Hug, et al.Clinical Nephrology|October 30, 2009
Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysisR Dikow, P Quentmeier, V Schwenger, et al.Kidney International|February 1, 1990
Fluid phase generation of terminal complement complex as a novel index of bioincompatibilityR Deppisch, V Schmitt, J Bommer, et al.Blood Purification|January 1, 1985
Response of alkaline phosphatase to zinc repletion in hypozincemic hemodialysis patientsG Stammler, P Klooker, J Bommer, et al.Clinical and Experimental Pharmacology & Physiology|March 1, 1982
Contribution of the sympathetic nervous system to the centrally-induced pressor action of angiotensin II in ratsJ F Mann, W Rascher, A Schömig, et al.Hypertension (Dallas, Tex. : 1979)|July 1, 1980
Central actions and brain receptor binding of angiotensin II: Influence of sodium intakeJ F Mann, E L Schiffrin, P W Schiller, et al.Nephron|January 1, 1990
Growth hormone induced rise in glomerular filtration rate is not obliterated by angiotensin-converting enzyme inhibitorsD Haffner, E Ritz, O Mehls, et al.Deutsche Medizinische Wochenschrift (1946)|January 3, 2004
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]A J Palmer, L Annemans, S Roze, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failureK Amann, C Nichols, J Tornig, et al.Pageof 67